Gassie Kelly, Wijesekera Olindi, Chaichana Kaisorn L
Department of Neurosurgery, Mayo Clinic, Jacksonville, FL, USA.
Department of Neurosurgery, Mayo Clinic, Jacksonville, FL, USA -
J Neurosurg Sci. 2018 Dec;62(6):682-689. doi: 10.23736/S0390-5616.18.04466-1. Epub 2018 Apr 18.
Deep-seated, subcortical tumors represent a surgical challenge. The traditional approach to these lesions involve large craniotomies, fixed retractor systems, and extensive white matter dissection, each with their own associated morbidity. We describe our experience with the use of tubular retractors for accessing these deep-seated lesions.
Fifty consecutive patients operated on for an intra-axial brain tumor (both biopsies and resection) from January 2016 to December 2017 by a single surgeon using tubular retractors with exoscopic visualization were prospectively identified and included in this consecutive case series.
Thirty-five patients (70%) underwent surgical resection and 15 (30%) underwent excisional biopsy for tumors located a median (interquartile range [IQR]) distance of 5.4 (4.5-6.1) cm below the cortical surface within the thalamus and/or basal ganglia in 12 (24%), centrum semiovale in 17 (34%), cerebellar in 8 (16%), peri-Rolandic in 6 (12%), visual tracts in 5 (10%), and intraventricular in 2 (4%). The median IQR percent resection was 100 (95-100)% and all patients had diagnostic tissue. Pathology was high grade glioma in 30 (60%), metastatic in 14 (28%), and cavernoma in 2 (4%). The postoperative median IQR KPS was 80 (80-90), where 18 (36%) had improved, 29 (58%) stable, and 3 (6%) worsened KPS as compared to preoperatively.
The tubular retractor is a useful tool in the armamentarium of brain tumor surgery, and the exoscope provides an ergonomic means of visualizing the surgical field. It is meant to be used as a tool to access and resect deep-seated lesions while preserving and displacing superficial white matter tracts and cortical regions, provide a protected corridor to minimize inadvertent tissue injury during the resection, and circumferential tissue retraction to minimize risk of ischemia and damage to white matter tracts. As with any procedure, there is a learning curve with this surgical adjunct.
深部皮质下肿瘤是手术的一大挑战。传统的治疗这些病变的方法包括大骨瓣开颅、固定牵开器系统以及广泛的白质分离,每种方法都有其相应的并发症。我们描述了使用管状牵开器处理这些深部病变的经验。
前瞻性地确定并纳入了2016年1月至2017年12月期间由一名外科医生使用管状牵开器并通过外视镜可视化技术对轴内脑肿瘤(包括活检和切除术)进行手术的50例连续患者,将其纳入这个连续病例系列。
35例患者(70%)接受了手术切除,15例(30%)接受了切除活检,肿瘤位于丘脑和/或基底节皮质表面以下中位数(四分位间距[IQR])5.4(4.5 - 6.1)cm处,其中12例(24%)位于此处,17例(34%)位于半卵圆中心,8例(16%)位于小脑,6例(12%)位于中央沟周围,5例(10%)位于视束,2例(4%)位于脑室内。切除组织的中位数IQR百分比为100(95 - 100)%,所有患者均获得了诊断性组织。病理结果为高级别胶质瘤30例(60%),转移瘤14例(28%),海绵状血管瘤2例(4%)。术后KPS中位数IQR为80(80 - 90),与术前相比,18例(36%)改善,29例(58%)稳定,3例(6%)恶化。
管状牵开器是脑肿瘤手术器械中的一种有用工具,外视镜提供了一种符合人体工程学的手术视野可视化方法。它旨在作为一种工具,用于接近和切除深部病变,同时保留和移位浅表白质束和皮质区域,提供一个受保护的通道以尽量减少切除过程中意外的组织损伤,并进行圆周组织牵开以尽量减少缺血风险和对白质束的损伤。与任何手术一样,这种手术辅助工具存在学习曲线。